CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 1 Study of GRN163L (Imetelstat) in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia That is in Second or Greater Relapse or That is Refractory to Relapse Therapy; Myelodysplastic Syndrome or Juvenile Myelomonocytic Leukemia in First or Greater Relapse or is Refractory to Relapse Therapy
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06247787
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:29:08.102889+00:00
- Published At
- 2026-04-20T00:00:00+00:00
- Record Updated At
- 2026-04-20
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Recurrent Childhood Acute Myeloid Leukemia", "Recurrent Childhood Myelodysplastic Syndrome", "Recurrent Juvenile Myelomonocytic Leukemia", "Refractory Childhood Acute Myeloid Leukemia", "Refractory Childhood Myelodysplastic Syndrome", "Refractory Juvenile Myelomonocytic Leukemia"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2026-04-20"- protocolSection.identificationModule.nctId
"NCT06247787"- protocolSection.identificationModule.officialTitle
"A Phase 1 Study of GRN163L (Imetelstat) in Combination With Fludarabine and Cytarabine for Patients With Acute Myeloid Leukemia That is in Second or Greater Relapse or That is Refractory to Relapse Therapy; Myelodysplastic Syndrome or Juvenile Myelomonocytic Leukemia in First or Greater Relapse or is Refractory to Relapse Therapy"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
["PHASE1"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.